NCT01995032View on ClinicalTrials.gov

L-citrulline and Metformin in Duchenne's Muscular Dystrophy

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions
Duchenne's Muscular Dystrophy (DMD)
Interventions
DRUG

750 mg metformin and 7.5 g L-citrulline daily p.o.

DRUG

Placebo

Trial Locations (1)

4031

University Children's Hospital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT01995032 - L-citrulline and Metformin in Duchenne's Muscular Dystrophy | Biotech Hunter | Biotech Hunter